The U.K.’s Bribery Act of 2010 has broad extraterritorial reach, and prohibits a wider range of conduct than the FCPA, making awareness of its enforcement and interpretation important for many multi-national companies.  A recent program organized by the Society of Corporate Compliance and Ethics (SCCE) provided an update on the Bribery Act from experienced U.K. practitioners.  Margaret Hambleton, CCO of Dignity Health and SCCE Board Member, hosted the program.  The speakers were Jonathan Armstrong, a partner in U.K. solicitors firm Cordery Legal Compliance, and André Bywater, a principal advisor at that firm.  See also “Corruption Risks and Anti-Corruption Strategies in the E.U.” (May 14, 2014).